Sort   by:  
 Page size 
UnknownLong-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Not available
S-EPMC7048161 | biostudies-literature
UnknownThe Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.
Not available
S-EPMC10566451 | biostudies-literature
UnknownCetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Not available
S-EPMC5847342 | biostudies-literature
UnknownBiomarker clustering in autosomal dominant Alzheimer's disease.
Not available
S-EPMC9525451 | biostudies-literature
UnknownComparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
Not available
S-EPMC6389727 | biostudies-literature
UnknownSerum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.
Not available
S-EPMC7363568 | biostudies-literature
UnknownVariant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.
Not available
S-EPMC8956209 | biostudies-literature
UnknownModeling autosomal dominant Alzheimer's disease with machine learning.
Not available
S-EPMC8195816 | biostudies-literature
UnknownComparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease.
Not available
S-EPMC7689410 | biostudies-literature
UnknownRegional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Not available
S-EPMC12260115 | biostudies-literature
Sort   by:  
 Page size